Search:
Home  About  Submit Site    
  
 
Lapatinib is classified as a signal transduction inhibitor - tyrosine kinase inhibitor, inhibitor of EGFR and HER2. Lapatinib is marketed as Tykerb and is used in the treatment of metastatic breast cancer that is HER-2 positive. The drug may also be used in combination with other chemotherapy drugs or for the treatment of other cancers.
Sites [ Submit ]
RxList: Tykerb (Lapatinib) - Provides medication description and drug information including side effects, interactions, and patient labeling.
Click [ Submit ] above to Add a New Site, Update a Site, or Remove a Site from this Category.
This directory is made available through a Creative Commons Attribution license from the DMOZ Organization.

© 2025 - Midnight Design Productions, LLC